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1. Introduction 
Human embryonic stem (hES) cells are pluripotent stem cells capable of self-renewal and 
differentiation into virtually all cell types (Thomson et al., 1998, Reubinoff et al., 2000). Thus, 
they hold tremendous potential as cell sources for regenerative therapies. Using endothelial 
cells for therapeutic angiogenesis/vasculogenesis of ischemia diseases has led to exploring 
hES cells as a potential source for endothelial progenitor cells. Due to the limitation 
pluripotency of hES cells, hES cells derived endothelial cells are advantageous when 
compared with other endothelial cell origin (Li et al., 2007, Li et al., 2009b). Understanding 
the in vivo behavior of transplanted cells requires novel imaging techniques to 
longitudinally monitor hES cells localization, proliferation, differentiation, and viability. 
Molecular imaging has given investigators a high-throughput, inexpensive, and sensitive 
means for tracking in vivo cell proliferation over times (Li et al., 2009a). This advancement 
has significantly increased the understanding of the spatiotemporal kinetics of hES cells 
engraftment in living animals and greatly expedited basic research prior to future clinical 
translation.  
In this chapter, the specific methods needed for tracking hES cells proliferation with 
bioluminescence imaging and in vitro endothelial differentiation of hES cells will be 
described. We first established stable hES cell line constitutively expressing double fusion 
reporter genes (enhanced green fluorescent protein and firefly luciferase) using lentiviral 
transduction (Li et al., 2009b). Unlike other methods of cell tracking, reporter genes are 
inherited genetically and can be used to monitor cell proliferation and survival of 
transplanted cells and daughter cells. Next, we introduced two-step procedures to increase 
endothelial differentiation efficiency of hES cells by subcultured embryoid bodies (EBs) in 
collagen. Using whole genome microarrays, we investigated the hES cells derived 
endothelial cells (hES-ECs) transcriptome that occur among sequenced hES cells 
differentiation processes and human umbilical vein endothelial cells (HUVECs). By 
intravital microscope, we demonstrated that hES-ECs can form function vessels with blood 
flow. To monitor cell survive and therapeutic potential of hES-ECs for ischemia diseases, we 
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then employed bioluminescence imaging techniques that allow noninvasive monitoring of 
transplanted hES-ECs engraftment. 
2. Molecular imaging methods for stem cell therapy 
For stem cell research to make the next quantum leap, it is imperative to understand the 
dynamic processes of hES cells homing, migration, biodistribution, proliferation, and 
differentiation in the same subject over time. The development of noninvasive imaging 
techniques is essential for conducting detailed preclinical studies to optimize the delivery 
methods and strategies that can enhance cell survival. A number of methods are available to 
track stem cells by molecular imaging. In general, there are two methods to label the cells: 
(1) direct labeling method, which physically introduce marker(s) into the cells before 
transplant; (2) indirect labeling method, which genetically introduce reporter gene(s) into 
the cells before transplant (Wu et al., 2004).  
2.1 Direct labeling methods  
For direct labeling, detectable probes can be loaded into or attached to the cells during 
tracking. Examples include labeling with super paramagnetic iron oxide (SPIO) for magnetic 
resonance (MR) imaging, 18F-fluoro-deoxy-glucose ([18F]-FDG) for positron emission 
tomography (PET) imaging, [111In]oxine for single-photon emission computerized tomography 
(SPECT), and quantum dots for fluorescence imaging. These techniques have been used for 
adult and embryonic stem cell imaging (Zhang et al., 2007). Although direct labeling can be 
used to evaluate the initial deposition of implanted stem cells, the imaging signals tend to 
diminish with cell division and proliferation or become undetectable after the decay of 
radioactive tracers. Another confounding factor with this type of labeling and imaging is that 
non-viable cells may still generate a robust MR signal, as shown in a recent study comparing 
iron labeling imaging (direct) versus reporter gene imaging (indirect)(Li et al., 2008).  
2.2 Indirect labeling methods 
Indirect imaging such as the reporter gene approach involves inserting reporter gene(s) into 
stem cells for the purpose of tracking. Products of reporter gene expression generally can be 
divided into 3 categories: enzyme-based (e.g., herpes simple virus type 1 thymidine kinase 
[HSV1-tk] or firefly luciferase [Fluc]), receptor-based (e.g., dopamine type 2 receptor [D2R]), 
and transporter-based (e.g., sodium-iodide symporter [NIS]). Stable transfection or 
transduction with reporter genes is useful in assessing kinetic survival status of the implanted 
cells because the reporter genes can be expressed as long as the cells are alive; the inserted 
reporter gene(s) can be passed on to daughter cells upon cell division. However, a major 
disadvantage for future clinical applications of reporter gene approach in cell tracking is the 
requirement for genetic manipulations of the cells, which may lead to insertional mutagenesis. 
Thus, the recent advances in site-specific chromosomal integration mediated by phiC31 
integrase may become a useful tool to overcome this obstacle (Thyagarajan et al., 2008).  
3. Endothelial differentiation of hES cells 
Due to the limitation of postnatal cell sources and expanding efficiency, endothelial 
differentiation of hES cells provide an alternative source to generate a large supply of 
healthy, functional cells. hES-ECs can be generated by two main approaches, spontaneous 
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differentiation of embryoid bodies (EBs), also called 3-dimensional differentiation (3D), and 
2-dimensional differentiation (2D) (Wang et al., 2007, Yamahara et al., 2008, Kaufman et al., 
2001). 
For the 3D differentiation, hES cells need to be cultured in low attachment dish for 9-13 
days(Levenberg et al., 2002, Li et al., 2008, Wang et al., 2007). Different mediums have been 
used with or without growth factors. Whole-mount immunostaining CD31 confirmed that 
hES cells cultivated as EBs spontaneously differentiated into endothelial cells and formed 
blood vessel like structure(Levenberg et al., 2002, Li et al., 2008). Subsequently, EBs were 
digested into single cells. Differentiated endothelial cells or hemangioblasts were sorted by 
fluorescence-ctivated cell sorting (FACS) or magnetic-activated cell separation (MACS). For 
the 2D differentiation, hES cells were cultured on various mouse fibroblast feeder layers, 
including mouse embryo fibroblasts (MEF) (Wang et al., 2007), OP9 (Yamahara et al., 2008, 
Vodyanik et al., 2005), S17 (Kaufman et al., 2001, Vodyanik et al., 2005), MS-5 (Vodyanik et al., 
2005), or mouse endothelial cells (Kaufman et al., 2001). hES cells also can be cultured on 
collagen IV-coated plates for endothelial differentiation (Gerecht-Nir et al., 2003). 
Both in vitro assays and in vivo transplantation have been used to characterize the hES 
derived endothelial cells. After in vitro subculturing, these cells express CD31, CD34, Flk-1, 
VE-cadherin and vWF. They are capable of DiI-ac-LDL uptake and can generate tube-like 
structure formation on Matrigel. For in vivo assay, hES-ECs can form a tube-like structure 
within Matrigel plug. Interestingly, postnatal hemangioblast cell markers such as KDR and 
CD133 are robustly expressed in undifferentiated hES cells (Chen et al., 2007, Li et al., 2008) 
and thus are not good markers for endothelial selection of hES cells differentiation. 
A major challenge of hES-based therapy is the generation of sufficient numbers of 
differentiated endothelial cells. The efficiency of endothelial differentiation of the 3D EB 
system is typically low, ranging from 1%-3% (Levenberg et al., 2002, Li et al., 2008). 
Moreover, it is difficult to get single cells from EBs by enzyme digestion as cell viability is 
low after this harsh digestion step. Several investigators have introduced modified 
approaches to bypass the 3D EB formation or serial differentiation procedures to increase 
differentiation efficiency (Cho et al., 2007, Lu et al., 2007). Wang et al. demonstrated that 
~10% CD34+ progenitor cells are present by monolayer culturing of hES cells on MEF for 10 
days (Wang et al., 2007). 
To optimize hES cells differentiation to endothelial lineage, we designed a staged protocol 
that involved EB formation (stage 1) and expansion of endothelial lineage by subcultured EB 
in collagen (stage 2). 
3.1 Maintenance and differentiation of human embryonic stem cells  
Undifferentiated hES cells (H9 line from Wicell, passages 35 to 45) were grown on an 
inactivated mouse embryonic fibroblast (MEF) feeder layer as previously described (Chen et 
al., 2007, Efroni et al., 2008). Briefly, the cell was maintained at an undifferentiated stage on 
irradiated low-passage MEF feeder layers on 0.1% gelatin-coated plates. The medium was 
changed daily. The medium consisted of Dulbecco's modified Eagle's medium (DMEM)/F-
12, 20% knockout serum replacement, 0.1 mM nonessential amino acids, 2 mM L-glutamine, 
0.1 mM β-mercaptoethanol, and 4 ng/ml rhFGF-2 (R&D Systems Inc., Minneapolis). The 
undifferentiated hES cells were treated by 1 mg/ml collagenase type IV in DMEM/F12 and 
scraped mechanically on the day of passage. To deplete feeder cells before endothelial 
differentiation, hES cells were cultured on Matrigel coated plates with mTeSR™1 medium 
(Stem Cell Technologies Inc, Vancouver, Canada).  
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3.2 Two-step In vitro differentiation of hES cells 
To induce hES cell differentiation, undifferentiated hES cells were cultured in differentiation 
medium containing Iscove's modified Dulbecco's medium (IMDM) and 15% defined fetal 
bovine serum (FBS) (Hyclone, Logan, UT), 1XBIT (BSA, insulin, transferring; Stem Cell 
Technologies), 0.1 mM nonessential amino acids, 2 mM L-glutamine, 450 μM 
monothioglycerol (Sigma, St. Louis, MO), 50 U/ml penicillin, and 50 μg/ml streptomycin, 
with 20ng/ml bFGF (R&D Systems Inc., Minneapolis) and 50ng/ml VEGF (R&D Systems 
Inc.), either in ultra-low attachment plates for the formation of suspended embryoid bodies 
(EBs) as previously described (Chen et al., 2007, Levenberg et al., 2002, Li et al., 2008).  Briefly, 
hES cells cultured on Matrigel coated plate with mTeSR™1 medium were treated by 2 
mg/ml dispase (Invitrogen, Carlsbad, CA) for 15 minutes at 37°C to loosen the colonies. The 
colonies were then scraped off, and transferred into ultra low-attachment plates (Corning 
Incorporated, Corning, NY) for EB formation. EB sprouting differentiation in collagen type I 
was performed as described(Li et al., 2005), with minor modifications. Briefly, 12 days-old 
EBs were harvested, and then suspended into rat tail collagen type I (Becton Dickinson, San 
Jose, CA) at a final concentration of 1.5 mg/ml collagen. After thoroughly mixing EBs into 
collagen, 1.5 ml/well of mixture were added into six-well-plate. The plates were incubated 
at 37°C for 30 min, allowing gel polymerization prior to addition of medium. After gel 
formation, each dish was supplemented with EGM-2 medium (Lonza, Basel, Switzerland) 
with 50ng/ml VEGF additional. The cultures were then incubated for 3 days without media 
change (Figure 1). 
 
 
Fig. 1. Specification of the endothelial lineage differentiation from hES cells. An outline of 
the protocol used for the differentiation of hES cells to the endothelial lineage. 
Undifferentiated hES cells were grown to 60%–70% confluence on Matrigel and subcultured 
in low attachment dish with differentiation medium supplement VEGF and bFGF, dated as 
day 0. At day 12, hEBs were collected and digested and CD31+/ CD144+ cells were isolated 
by FACS and sub-cultured in EGM-2 medium to expand and induce endothelial maturation 
After embedded into collagen, EBs rapidly developed into vascular sprouting in the 
presence of growth factors within 3-4 days. Whole-mount immunostaining confirmed that 
CD31+ and CD144+ cells were organized into channel-like structures within day-12 EBs 
(Figure 2A). These data demonstrate that some cells within EBs can spontaneously 
differentiate into endothelial cells that are then able to form blood vessel-like structures, 
confirming previous reports from our lab and others (Levenberg et al., 2002, Li et al., 2008, 
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Wang et al., 2007). CD31/CD144 expression increased swiftly to 10-15% after subculture in 
collagen as confirmed by FACS analysis, as compared to 1-2% using the conventional EB 
culturing technique (Figure 2B). After sorting, CD31+/CD144+ cells were further expanded 
as a nearly pure population (98%) and these cells were used for subsequent experiments. 
 
 
Fig. 2. Specification of the endothelial lineage differentiation from hES cells. (A) Endothelial 
differentiation of sprouting hEBs in collagen. Representative sprouting hEBs after cultured 3 
days in collagen matrix (upper panel, left). Whole-mount immunostaining showed CD31 
sprouting with channel-like vessel structures and CD31 cell clumps (upper panel). Also, 
those sproutings are CD31 and CD144 double positive. (B) Kinetic expression of CD31 and 
CD144 during two-step hES cells differentiation procedures. hES-ECs were enriched by 
CD31+/CD144+ isolation (right panel) 
3.3 Flow cytometry sorting (FCS) of hES-ECs  
Single cell suspension from hEB-sprouting was obtained by treatment with 0.25% 
collagenase I (Invitrogen, Carlsbad, CA) at 37°C for 20-30 min, then with 0.56 units/ml 
Liberase Blendzyme IV (Roche Diagnostics, Indianapolis) at 37 °C for 10-20 minutes. Cells 
were passed through a 40- μm cell strainer (BD Falcon, San Diego) (Xu et al., 2006). Cells 
were incubated with mouse anti-human CD31 (BD) and CD144 (Abcam, Cambridge, MA). 
The CD31+/CD144+ cells were isolated using FACScan (Becton Dickinson). To generate hES-
ECs, the isolated CD31+/CD144+ cells from hEB-sprouting were grown on 4 μg/cm2 human 
fibronectin (Calbiochem, San Diego, CA) coated plates in EGM-2 (Lonza) with additional 5 
ng/ml VEGF. The medium was changed every 2–3 days. 
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3.4 Biological characteristics of hES-ECs  
Flow cytometry analysis, immunostaining, DiI-ac-LDL uptake assay, and Matrigel assay 
were used to confirm endothelial cell phenotype within these CD31+/CD144+ purified hES 
cells.  Antibodies used for flow cytometry analysis were phycoerythrin (PE) conjugated anti-
CD31, CD34 (BD Pharmingen) and Allophycocyanin (APC) conjugated anti-KDR, CD133 
(R&D Systems), APC conjugated anti-mouse IgG2a, and rabbit anti-human CD144 (Abcam). 
The stained cells were analyzed using FACS Vantage (Becton-Dickinson, MA). Dead cells 
stained by propidium-iodide (PI) were excluded from the analysis. Isotype-identical 
antibodies served as controls (BD Pharmingen).  
For immunostaining, the cells were fixed with with 4% paraformaldehyde in PBS at room 
temperature for 15 minutes. The fixed cells were permeated by 1% Triton 100 and incubated 
with 2% BSA for 30 minutes to block nonspecific binding, and stained for 1 hour with the 
primary antibodies: CD31, CD144 (BD Pharmingen) and vWF (Chemicon International Inc), 
respectively. The cells were then incubated for 30 minutes with either Alexa 593-conjugated 
donkey anti-mouse secondary antibody or Alexa 488-conjugated donkey anti-rabbit 
secondary antibody (Invitrogen), and counter stained with DAPI. 
For DiI-ac-LDL uptake assay, hES-ECs were incubated with 10 μg/ml of DiI-Ac-LDL 
(Molecular Probes, Eugene, OR) at 37°C for 6 hours. After washing with PBS twice, cells 
were fixed and counterstained with DAPI (4, 6-diamidino-2-phenylindole) as described 
(Chen et al., 2007). The formation of endothelial tubes was assessed by seeding cells in 24-
well plates coated with Matrigel (BD Pharmingen) and incubating them at 37° for 12 hours 
as described(Li et al., 2007). 
hES-ECs morphologically resembled HUVECs, which were uniformly flat, adherent, and 
cobblestone-like in appearance. When CD31+/CD144+ cells were cultured in endothelial 
growth medium, the majority of cells were adherent and expressed endothelial markers 
(CD31, CD144) at the endothelial cell adherent junctions as well as von Willebrand factor 
(vWF) located within the cytoplasm (Figure 3A). The CD31+/CD144+ cells also uptake DiI-
acetylated low-density lipoprotein, and rapidly formed vascular network-like structures 
when placed on Matrigel (Figure 3B). Taken together, these data confirm that these 
differentiated cells were of endothelial lineage. 
 
 
Fig. 3. In vitro characterization of hES-EC. (A) Morphogenesis shows the cells were cobble 
stone like; histology show CD31 and CD144 express on cell membranes, and vWF in the 
cytoplasm. (B) Compare to HUVEC, hES-ECs also can uptake ac-DiI-LDL and form tube like 
structure on Matrigel 
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3.5 Microarray hybridization and data acquisition 
In order to define at a molecular level the changes occurring at each stage of hES cells 
differentiation to endothelial progeny, and to validate that these cells are similar to human 
umbilical vein endothelial cells (HUVECs), we also perform transcriptional profiling using 
whole human genome microarrays and real-time PCR arrays. Total RNA samples were 
isolated in Trizol (Invitrogen) followed by purification over a Qiagen RNeasy column 
(Qiagen) from undifferentiated hES cells at day 0, differentiated hEBs at day 12, hES-derived 
endothelial cells (after CD31/CD144 sort), and human umbilical endothelial cells (HUVEC). 
Four samples from each group (for a total of 16 unique samples) were harvested for RNA 
isolation. Using Agilent Low RNA Input Fluorescent Linear Amplification Kits, cDNA was 
reverse transcribed from each of 16 RNA samples representing four biological 
quadruplicates, as well as the pooled reference control, and cRNA was then transcribed and 
fluorescently labeled with Cy5/Cy3. cRNA was purified using an RNeasy kit (Qiagen, 
Valencia, CA, USA). 825 ng of Cy3- and Cy5- labeled and amplified cRNA was hybridized 
to Agilent 4x44K whole human genome microarrays (G4112F) and processed according to 
the manufacturer’s instructions.  The array was scanned using Agilent G2505B DNA 
microarray scanner. The image files were extracted using Agilent Feature Extraction 
software version 9.5.1 applying LOWESS background subtraction and dye-normalization. 
 
 
Fig. 4. Major themes in gene expression profiles at each stage of differentiation. (A) hES cells 
express high levels of pluripotency-associated genes including Oct4, Sox2, NANOG, Lefty, 
and DNMT. At the EB stage, the cells express high levels of mesodermal master regulators 
such as Tbx2, and BMP4 as well as very enriched levels of endothelial specific master 
regulators including EPAS1, TIE2, KDR, and EFNA. This population also expresses genes 
from other cell layers, and many developmental genes from Wnt and homeobox families. 
hES-ECs downregulate early mesodermal genes and express more endothelial specific 
genes, while HUVECs have the highest levels of mature endothelial gene expression with 
very few other developmental lineages represented 
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The resulting data were analyzed using GeneSpring GX 7.3.1 to identify genes which had 
changed expression significantly between stages. A summary of our major findings is 
shown in Figure 4. To obtain an overview of the transcriptional landscape, we looked at the 
data using principal components analysis (PCA), a dimensional reduction technique which 
identifies "principal components" or major trends in gene expression in the overall data 
(Figure 5). PCA demonstrates that each of the four replicates from each stage has very 
similar transcriptional profiles to one another, but distinctly different between stages, as 
expected. 
 
Fig. 5. Principal Components Analysis (PCA) shows that replicate experiments of each cell 
type are very similar while differentiation groups separate significantly along components 1 
and 2 
3.6 Real time RT-PCR (qRT-PCR) 
To investigate changes in endothelial related genes during endothelial cell differentiation in 
collagen, we performed quantitative real-time PCR analysis using the Human Endothelial 
Cell Biology PCR array on undifferentiated hES cells, EBs, EB sprouting, and hES-ECs, and 
on HUVEC as a positive control. qRT-PCR assays were performed using the human 
endothelial cell biology RT2 ProfilerTM PCR Array (SuperArray Bioscience, Frederick, MD) 
on an ABI PRISM 7900 HT (Applied Biosystems, Foster City, CA). Data analysis is available 
at the company website (http://www.superarray.com/pcr/arrayanalysis.php). Briefly, total 
RNAs were isolated using RNeasy  (Qiagen, Waltham, MA) from undifferentiated hES cells 
at day 0, differentiated hEBs at day 12, hEB-sprouting, hES-derived endothelial cells (after 
CD31/CD144 sort), and human umbilical endothelial cells (HUVEC) as positive control.  
First-strand cDNAs were generated using iScript Select cDNA Synthesis Kit (BioRad, 
Hercules, CA). For real-time PCR reaction, first-strand cDNAs were added to RT qPCR 
Master Mix (SuperArray Bioscience). Samples were heated for 10 min at 95°C and then 
subjected to 40 cycles of denaturation at 95°C for 15 sec and annealing and elongation at 
60°C for 1 min. 
Analysis of scatter plot demonstrated 28 genes were upregulated when day-12 EBs were 
embedded into collagen type I for an additional 3 days (Figure 6A). Analysis of scatter plots 
also revealed that 30 genes were upregulated and 8 genes downregulated after 
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undifferentiated hES cells differentiated into EBs, and 33 genes upregulated and 2 genes 
downregulated after hES cells differentiated into EB sprouting. Quantitative analysis 
showed after endothelial induction, ICAM1, CD31, VCAM1, and vWF were significantly 
upregulated, while FGF1, Flt1, KDR and VEGFA were expressed in undifferentiated cells 
and upregulated with endothelial differentiation of hES cells (Figure 6B), which were also 
consistent with the microarray data. To explore the mechanism of promotion of endothelial 
differentiation in collagen, quantitative analysis was carried out and showed that 
endothelial cell activation genes were upregulated swiftly and endothelial differentiation 
was triggered after hEBs were embedded into collagen (Figure 6C). 
 
 
Fig. 6. Quantitative PCR analysis of endothelial gene in hES, hEB, hEB sproutin, hES-EC and 
HUVEC. (A) Scatter plots of the endothelial related gene-expression were compared 
between hES and hEB, hES and sprouting , and hEB and sprouting . Endothelial related 
genes expression was analyzed by Human Endothelial Cell Biology RT2 Profiler PCR Array. 
The array includes 84 genes related to endothelial cell biology. The lines indicate the 
diagonal and 4-fold changes between the two samples. (B) Kinetic expression of selected 
endothelial gene on hES, hEB, sprouting and hES-EC between HUVEC. Compared to 
HUVEC, hES-ECs express abundant endothelial gene except adult endothelial gene vWF. 
(C) Cell matrix related gene increase swiftly in collagen regardless beginning level 
4. Imaging fate of transplanted hES-ECs 
Stem cell therapy is an exciting area of research that promises future treatment of many 
diseases (Chiu, 2003). However, to fully understand the beneficial effects of stem cell therapy, 
investigators must be able to track the biology and physiology of transplanted cells in living 
subjects over time. At present, most cell therapy protocols require histological analysis to 
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determine viable engraftment of the transplanted cells. The development of sensitive, 
noninvasive technologies to monitor this fundamental engraftment parameter will greatly aid 
clinical implementation of cell therapy. Therefore, to validate the in vivo engraftment potential 
of our hES-ECs, we performed noninvasive monitoring of transplanted hES-ECs in a murine 
myocardial ischemia model by bioluminescence imaging (BLI). 
Among the different reporter gene imaging techniques, bioluminescence imaging (BLI) is 
extremely useful because of its high sensitivity, high-throughput screening, and 
straightforward imaging procedures. Firefly luciferase (Fluc) is a 61-kDa monomeric protein, 
which reacts with its substrate D-luciferin in the presence of oxygen, Mg2+, and ATP to emit 
luminescence. The light can be captured by high sensitive CCD camera, such as IVIS 
imaging system (Caliper Life Sciences, Mountain View, CA). This imaging modality is 
currently limited to small animal models, because bioluminescence imaging relies on low-
energy photons (2-3 eV) that become attenuated within deep tissues. Recent work 
demonstrated that hES cells can be stably transduced with a lentiviral vector carrying a 
novel double-fusion reporter gene that consists of firefly luciferase and enhanced green 
fluorescence protein (Fluc-eGFP) (Li et al., 2008). Reporter gene expression has shown no 
significant adverse effects on hES cells viability, proliferation, or differentiation into hES-
ECs. After transplantation into the mouse hindlimb, hES-ECs can be tracked up to 4 week by 
BLI. Moreover, postmortem histology can be used to confirm engraftment of transplanted 
hES-ECs based on GFP immunostaining. Finally, the reporter gene approach may also 
permit longitudinal monitoring of endothelial differentiation process. 
4.1 Lentiviral transduction of hES cells with double fusion (DF) reporter gene 
In order to track transplanted cells in vivo, hES cells were transduced at multiplicity of 
infection (MOI) of 10 with self-inactivating (SIN) lentiviral vector carrying a human 
ubiquitin promoter driving firefly luciferase and enhanced green fluorescence protein (Fluc-
eGFP) (Figure 7A). Stable clones were isolated using FACS for eGFP expression. 
Afterwards, Fluc activity within different cell numbers was confirmed ex vivo using 
Xenogen IVIS 200 system (Xenogen, Alameda, CA) as described (Cao et al., 2006). Non-
transduced hES cells (control) and hES cells with DF reporter gene (hES-DF) were stained 
for Oct-4 (Chemicon, Temecula, CA). The undifferentiated hES cell colonies were fixed in 
4% paraformaldehyde in PBS for 15 minutes. Nonspecific binding was blocked with 4% 
normal goat serum for 30 minutes, following which the colonies were stained with 
antibodies to Oct-4 and incubated with Alexa 594-conjugated rabbit anti-goat secondary 
antibodies (Invitrogen) for 30 minutes and nuclear counterstained with DAPI.  Images were 
obtained with a Zeiss Axiovert microscopy (Sutter Instrument Co., USA). Subsequently, the 
processes for in vitro endothelial cell differentiation and characterization were the same as 
control non-transduced hES cells described earlier. 
The efficiency of self-inactivating lentiviral vector for transducing hES cells was ∼20% (data 
not show). Both control non-transduced hES cells and stably transduced hES cells showed 
similar expression patterns of stem cell markers Oct-4 on immunostaining, suggesting 
minimal side effects by reporter gene on maintaining stem cell state (Figure 7B).  Upon 
culturing onto 24-well plates, we also observed a strong correlation (r2=0.99) between Fluc 
activity and cell numbers ex vivo using the Xenogen IVIS system (Figure 7C). The cell 
proliferation and cell viability data are also similar between control hES cells and 
transduced hES cells (data not shown).  Overall, these data are consistent with our previous 
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studies showing minimal effects of reporter genes on mouse ES cell survival, proliferation, 
and differentiation (Cao et al., 2006, Wu et al., 2006a, Wu et al., 2006b). 
 
 
Fig. 7. Stable lentiviral transduction of hES cells with the double fusion reporter genes. (A) 
Schema of the double fusion reporter gene containing fusion of Fluc-sGFP. The double 
fusion reporter gene was cloned into a self-inactivating lentiviral vector downstream from 
the ubiquitin promoter. (B) Control hES cells and transduced hES cells showed similar 
expression pattern of Oct-4 under fluorescence microscopy. DAPI staining is used as a 
nuclear marker. (C) Ex vivo imaging analysis of stably transduced cells show increasing 
bioluminescence signals with cell numbers of hES cells (r2=0.99). Data are representative of 
three independent experiments. Abbreviations: DAPI, 4’, 6-diamidino-2-phenylindole 
4.2 Longitudinal bioluminescence imaging of hES cell survival in living animals 
Previous studies have demonstrated that hES-derived cardiomyocyte transplantation can 
improve cardiac function after myocardial infarction (van Laake et al., 2007, Laflamme et al., 
2007). To understand the therapeutic potential of hES-ECs for treatment of ischemia heart 
disease, we subjected SCID mice to LAD ischemia and reperfusion followed by injection 
with either 1x106 cultured hES-ECs (n=28) or PBS (n=15). For sham operated animals (n=5), 
open thoracotomy was performed without ligation of the LAD and without injection of hES-
ECs or PBS. All surgical procedures were performed on 8-10 week old female SCID Beige 
mice (Charles River Laboratories, Wilmington, MA) by a single experienced micro-surgeon. 
Protocols were approved by the Stanford University Animal Care and Use Committee 
guidelines. Following induction with inhaled isoflurane (2% to 3%), mice were intubated 
and ventilated and anesthesia was maintained with inhaled isoflurane (1% to 2.5%). A left 
thoracotomy was performed followed by ligation of the middle of left anterior descending 
(LAD) artery for 30 minutes followed by reperfusion. Infarction was visually confirmed by 
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blanching of the anterolateral region of the left ventricle along with dyskinesis. After 30 
minutes, 1×106 hES-ECs were injected intramyocardially into the peri-infarct zone at 20 µl of 
total volume. Control animals received PBS injection instead. For sham operated animals, 
suturing was performed without ligation. Post-operative analgesia was provided by a one-
time, subcutaneous injection of buprenorphine (0.1 mg/kg body weight). Animals were 
recovered in a warmed, humidified chamber. 
Cardiac bioluminescence imaging was performed using the Xenogen IVIS 200 system. After 
intraperitoneal injection of the reporter probe D-Luciferin (150 mg luciferin/kg), animals 
were imaged for 1-10 minutes. The same mice were imaged for up to 8 weeks. 
Bioluminescence signal was quantified in units of maximum photons per second per cm 
square per steridian (photons/sec/cm2/sr). Injection of hES-ECs into infarcted myocardium 
resulted in a robust bioluminescence signal at day 2. However, serial imaging of the same 
animals out to 8 weeks demonstrated a significant decay in bioluminescence, suggesting 
acute donor cell death. When normalized to the signal on day 2 after injection, the percent 
bioluminescence signals were 36.8±15.5 at day 4, 6.7±1.5 at day 7, 3.5±0.6 at day 14, 2.3±0.5 at 
day 28, and 0.8±0.4 at day 56 (Figure 8). Thus, we believe less than 1% of transplanted hES-
ECs survived beyond 8 weeks. 
 
 
Fig. 8. Molecular imaging of hES-EC fate after transplantation. (A) A representative animal 
injected with 1x106 hES-ECs shows significant bioluminescence activity at day 2, which 
decreases progressively over the following 8 weeks. A representative control animal injected 
with PBS shows no imaging signals as expected.  (B) Detailed quantitative analysis of signals 
from all animals (n=28) transplanted with hES-ECs (signal activity is expressed as 
photons/sec/cm2/sr). (C) Donor cell survival plotted as % signal activity from day 2 to week 8 
4.3 Assessment of cardiac viability following hES-EC based therapy by PET imaging 
Small animal PET imaging was carried out at day -7 (baseline) and days 2, 14, 28, and 56, 
post-operatively. Mice were fasted for 3 hours prior to radioisotope injection and then were 
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injected with 140±17 µCi of [18F]-FDG via the tail vein. At 45 to 60 minutes post-injection, 
animals were anesthetized with inhaled 2% isoflurane and imaged with a Vista microPET 
system (GE Health Care). Images were reconstructed by filtered back projection (FBP) and 
analyzed by image software Amide (http://amide.sourceforge.net/index.html). Three-
dimensional regions of interest (ROIs) were drawn encompassing the heart. 
Counts/pixel/min were converted to counts/ml/min (assuming a tissue density of 1 g/ml) 
with a calibration constant derived from scanning a cylindrical phantom (Toyama et al., 
2004). For each ROI, counts/ml/min were then converted to counts/gram/min and divided 
by the injected dose to obtain the image ROI-derived [18F]-FDG percentage injected dose per 
gram of heart (% ID/g). To measure the myocardium infarction size, [18F]-FDG PET images 
were assembled into polar maps (Kudo et al., 2002). The size of perfusion defects was 
measured as the myocardium with 50% of maximum activity and expressed as percent total 
myocardium polar map by GE Healthcare Advantage Workstation (GE Healthcare, UK). 
Myocardial metabolic activity and perfusion defect imaging can be detected using a 
microPET system and 18F-fluorodeoxyglucose ([18F]-FDG) radiotracer (Kudo et al., 2002). 
This technique can be used to accurately detect changes in cardiac viability following  
 
 
Fig. 9. [18F]-FDG PET imaging of cardiac viability. (A) Representative polar map of the 
microPET images obtained from mice treated with PBS vs. hES-ECs. (B) Measurements are 
based on 50% thresholds. *P<0.05 vs. PBS group at day 14 
infarctions in small animal models (Schelbert et al., 2003). Therefore, we performed [18F]-
FDG PET scans at baseline, day 2, day 14, day 28, and day 56 post infarction for hES-EC 
treated and control animals. We observed a significant reduction in cardiac [18F]-FDG 
uptake for both groups at day 2, confirming successful myocardial infarction. At day 14, 
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there was a significant increase in cardiac viability (indicated by increased [18F]-FDG 
uptake) in the hES-EC treated group compared to controls (26.3±1.8 vs. 22.4±3.4; P<0.05). 
Analysis of the [18F]-FDG PET images using polar-map reconstruction revealed reduced 
infarction size on the hES-EC transplantation group compared to the PBS group, but there 
was no significant difference at any day other than day 14 (Figure 9). Overall, the trends for 
changes in functional contractility and metabolic activity were very similar based on the 
microPET imaging results. 
4.4 Histologic assessment of hES-ECs engraftment  
Histologic analysis of the myocardium was performed by examining thin sections of the 
gross specimen and via immunofluorescent microscopic examination. Microscopic 
examination showed the presence of GFP positive cells within myocardium (Figure 10). At 
day 4, clumps of hES-ECs can be found in the interstitial spaces between cardiomyocytes, as 
seen with -sarcomeric actin (-SA) and GFP double staining (Figure 10A). At day 28, GFP, 
-SA, and mouse-specific CD31 triple staining revealed hES-ECs that had formed 
microvessel structures and integrated with host vasculature. However, the overall frequency 
of GFP+ cells was significantly decreased at day 28 (Figure 10B, C), which is consistent with 
the decrease in bioluminescence signals measured over this same period of time and likely 
due to massive cell death. Moreover, immunostaining with mouse CD31 and -SA at day 4  
 
 
Fig. 10. Confirmation of engrafted hES-ECs by immunofluorescence. (A) hES-ECs within the 
recipient myocardium 4 days after injection showed clump formation. (B, C) At day 28, 
transplanted hES-ECs can differentiate into vasculature and integrate with host 
myocardium as confirmed by GFP, mouse CD31, and -sarcomeric actin (-SA) co-staining. 
However, this population became significantly rare compared to day 4 
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showed no host vasculature extension into the hES-EC clumps (data not shown), which 
suggests no direct nutrient transport to transplanted cells other than diffusion. Finally, 
examination of the explanted hearts showed a downward trend in infarct size and an 
upward trend in microvascular density (MVD) in the hES-EC treated group, though these 
differences with controls were not statistically significant (data not shown). 
4.5 Functional imaging with intravital microscope 
To understand whether hES-ECs also possess vasculogenic ability in vivo, we next evaluated 
the in vivo vascular formation potential of hES-ECs after transplantation in the model of 
mouse dorsal window chamber. Previous data showed that supporting fibroblast cells were 
needed to stabilize engineered blood vessels (Au et al., 2008, Wang et al., 2007). However, 
there are obvious drawbacks in using mouse support cells in study of vessel maturation of 
human cell. In this study, we introduced collagen type I and Matrigel, without support cells, 
and showed hES-ECs can form functional vasculature and are stable up to 2 months post 
transplantation. Briefly, one million hES-ECs were suspended in 1 ml solution of rat-tail 
type I collagen (at final concentration 1.5 mg/ml) (BD) and Matrigel (BD) (1:1) at 4°C. The 
cell suspension was pipetted into 12-well plates and warmed to 37°C for 30 minutes to allow 
polymerization of collagen and Matrigel and 1 ml EGM-2 medium was added after that 
(Figure 11A). After one day of culture in 5% CO2, a skin puncher was applied to create 
circular disk-shape pieces of the construct (8-mm diameter), and they were implanted into 
 
 
Fig. 11. Demonstration of functional vessels in vivo using Matrigel plug and dorsal window 
chamber. (A) Dorsal window chamber model in SCID mice. GFP+ hES-ECs were cultured in 
a mix of collagen and Matrigel for 1 day (left, upper panel), and implanted into dorsal 
windows in SCID mice (middle, upper panel). Images were taken at day 2, 14 and 21 after 
implantation. After 14 days, Angiosense 680 was injected by tail vein to highlight perfused 
vessels within the dorsal window. Green, hES-ECs expressing GFP; red, functional blood 
vessels with contrast enhanced by Angiosense 680 
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the dorsal skin fold windows in SCID mice. The titanium dorsal skin fold chamber (APJ 
Trading Co. Inc, Ventura, Ca) surgically mounted onto each mouse was described 
previously(Lehr et al., 1993). Briefly, mice were anesthetized with inhaled isoflurane (2%–
3%), and two symmetrical titanium frames were implanted to sandwich the extended 
double layer of the skin. One layer was removed in a 10-mm-diameter circular area. The 
remaining layer, consisting of epidermis, subcutaneous tissue, and striated skin muscle, was 
covered with a glass coverslip incorporated in one of the titanium frames (Figure 11B). The 
animals were housed one per cage and had free access to water and food throughout the 
experiment. A recovery period of 2 days was allowed before the collagen/Matrigel patch 
was transplanted. Multiphoton laser-scanning intravital microscopy (IV-100, Olympus, 
Center Valley, PA) was used to visualize and quantify the morphological changes of EGFP-
expressing hES-ECs. 
To test whether the engineered vascular networks integrated with the host murine 
circulatory system, we next injected Angiosense 680 intravenously to enhance the contrast of 
perfused vessels. Importantly, several of the hES-EC derived vessels formed conduits that 
contained blood flow from day 12 to day 60 (Figure 11, D, E & F). In summary, these data 
suggest that transplanted hES-ECs have angiogenic potential and are able to integrate into 
the host vasculature. 
5. Conclusion 
Taken together, the results showed that endothelial output efficiency was increased by a 
novel two-step differentiation of hES cells with collagen, and hES-ECs possess functional 
vasculogenic ability in vivo. However, the numbers surviving hES-ECs in infarcted tissue 
decreased significantly in the first few weeks and improved heart function at 2 weeks, but 
not to a significant degree later, demonstrating the requirement for long-term follow-up in 
all cardiac cell transplantation studies. Alternative transplantation protocols with larger 
numbers of hES-ECs, multiple grafts, or addition of matrix or prosurvival factors to prevent 
donor cell death after transplantation could eventually lead to the realization of further and 
sustained enhancement of heart function post myocardial infarction. These data suggest that 
prolonged heart function recovery may require more permanent graft survival of 
transplanted cells. In conclusion, two-step differentiation of hES cells can provide sufficient 
and functional endothelial cells for cell therapy, but exploring alternative transplant 
protocols that can improve cell survival and lead to sustained enhancement of heart 
function post infarction should be introduced in future. Furthermore, we believe molecular 
imaging will likely play a critical role in monitoring the localization and viability of these 
transplanted cells for cardiovascular diseases. 
6. Prospect 
Cardiovascular disease (CVD) accounts for approximately 30% of all deaths in the United 
States (Rosamond et al., 2008). Since CVD is primarily caused by endothelial dysfunction, 
therapeutic angiogenesis/vasculogenesis holds great promise for a potential cure. The logic 
behind angiogenesis/vasculogenesis is to improve the spontaneous healing process by 
supplementation of vascular progenitor cells or growth factors(Li et al., 2007). Endothelial 
progenitor cell transplantation can foster the formation of arterial collaterals and promote 
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the regeneration of damaged tissues. Recently, human embryonic stem (hES) cells have 
generated much interest because of their capacity for self-renewal and pluripotency. In 
practical terms, hES cells can be cultured indefinitely ex vivo, and can differentiate into 
virtually any cell type in the adult body (Thomson et al., 1998, Reubinoff et al., 2000). hES 
cells are thus an attractive source for the derivation of large numbers of cells to be used in 
various tissue repair and cell replacement therapies. However, upon transplantation into 
living organisms, undifferentiated hES cells can spontaneously differentiate into rapidly 
proliferating teratomas, which are disordered amalgam of all three germs layers 
(Thomson et al., 1998, Reubinoff et al., 2000). Therefore, safely coaxing hES cells into 
committed progenitor lineages for therapeutic applications is an innovative and feasible 
strategy that can minimize the risk of cellular misbehavior and teratoma formation.  
At present, hES cells are in the approval process for use in the treatment of 
neurodegenerative disease and Stargardt’s Macular Dystrophy (SMD) by the Food and 
Drug Administration (FDA) of United States (Sun et al., 2010). The isolation of hES-
derived endothelial cells (hES-ECs) may also have potential therapeutic applications, 
including cell transplantation for repair of ischemic tissues and tissue-engineered vascular 
grafts. However, to fully understand the beneficial effects of stem cell therapy, 
investigators must be able to track the functional biology and physiology of transplanted 
cells in living subjects over time. At present, most cell therapy protocols are limited by 
their requirement for histological analysis to determine viable engraftment of the 
transplanted cells. The development of sensitive, noninvasive technologies to monitor this 
fundamental engraftment parameter will greatly aid clinical implementation of cell 
therapy. Moreover, recent research on hES-based therapy showed poor long-term 
engraftment of hES-ECs by serial bioluminescence imaging (Li et al., 2008). Thus, to 
sustain long-term engraftment of hES-ECs and realize the full benefits of hES-EC 
therapies, alternative transplantation protocols with addition of matrix (Cao et al., 2007) or 
pro-survival factors (Laflamme et al., 2007) to prevent cells death after transplantation 
must be developed. 
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